Bill > HF2022

This bill amends Minnesota Statutes 2020, Section 148.56, Subdivision 1, which defines the practice of optometry. The key changes are: (1) removing the prohibition on optometrists administering legend drugs intravenously, intramuscularly, or by injection, except for the treatment of anaphylaxis; (2) allowing optometrists to perform intravitreal injections; and (3) removing restrictions on optometrists prescribing or administering certain oral legend drugs, such as Schedule II and III drugs, oral steroids, oral antivirals, and oral carbonic anhydrase inhibitors. The bill aims to modify the limitations on prescribing and administering certain drugs by optometrists and make technical changes to the existing law.